| 1 | directed | 2,423 |
| 2 | aiming | 998 |
| 3 | looking | 664 |
| 4 | looked | 557 |
| 5 | pointing | 300 |
| 6 | looks | 215 |
| 7 | geared | 64 |
| 8 | striving | 41 |
| 9 | arrives | 25 |
| 10 | gazing | 11 |
| 11 | d-aib | 8 |
| 12 | 'pain-free | 4 |
| 13 | hypo-intense | 4 |
| 14 | militates | 4 |
| 15 | bruising/hematoma | 3 |
| 16 | glances | 3 |
| 17 | leans | 3 |
| 18 | parity/age | 3 |
| 19 | thermostatted | 3 |
| 20 | 'friends | 2 |
| 21 | /area | 2 |
| 22 | /rtv | 2 |
| 23 | ap-plied | 2 |
| 24 | chorizo | 2 |
| 25 | frangible | 2 |
| 26 | l-lysine-hcl | 2 |
| 27 | linac-mr | 2 |
| 28 | mri-targeted | 2 |
| 29 | resentments | 2 |
| 30 | signposting | 2 |
| 31 | 'biased | 1 |
| 32 | 'pid | 1 |
| 33 | -admscs | 1 |
| 34 | -adsorber | 1 |
| 35 | -bonding | 1 |
| 36 | -stereospecificity | 1 |
| 37 | .74-.97 | 1 |
| 38 | .trends | 1 |
| 39 | /gssg | 1 |
| 40 | /mfv | 1 |
| 41 | /obesity | 1 |
| 42 | 0.20mg/ml | 1 |
| 43 | 0.546±0.027 | 1 |
| 44 | 117±33 | 1 |
| 45 | 13°c/w | 1 |
| 46 | 16.1/100py | 1 |
| 47 | 16.7t/ha | 1 |
| 48 | 161±46 | 1 |
| 49 | 18/5m | 1 |
| 50 | 18α-ga | 1 |
| 51 | 1в | 1 |
| 52 | 201±30 | 1 |
| 53 | 312±48 | 1 |
| 54 | 4.3μg/ml | 1 |
| 55 | 4.6±2.8°c | 1 |
| 56 | 5.85+/-0.63 | 1 |
| 57 | 65.9/100py | 1 |
| 58 | 7,233 | 1 |
| 59 | 8.6t/ha | 1 |
| 60 | =.90-.95 | 1 |
| 61 | acarabose | 1 |
| 62 | andlook | 1 |
| 63 | arylguanidines | 1 |
| 64 | b-cranberry | 1 |
| 65 | babbled | 1 |
| 66 | benevolently | 1 |
| 67 | carbodiamide | 1 |
| 68 | cd4-cd8+high | 1 |
| 69 | ch58 | 1 |
| 70 | clostridiales-dominated | 1 |
| 71 | crosssensitivity | 1 |
| 72 | dendritogenesis | 1 |
| 73 | equalising | 1 |
| 74 | erring | 1 |
| 75 | excelling | 1 |
| 76 | fabricii | 1 |
| 77 | helenien | 1 |
| 78 | liposomes/cell | 1 |
| 79 | mini-bioreactors | 1 |
| 80 | multiple-dosages | 1 |
| 81 | nct02038062 | 1 |
| 82 | normocreatininemic | 1 |
| 83 | not-confident | 1 |
| 84 | o-mri | 1 |
| 85 | omega-umbilicoplasty | 1 |
| 86 | owieża | 1 |
| 87 | participants/investigators | 1 |
| 88 | pfoawastreated | 1 |
| 89 | post-adsorber | 1 |
| 90 | post-prayer | 1 |
| 91 | postcalcination | 1 |
| 92 | precalibrated | 1 |
| 93 | prophylacctically | 1 |
| 94 | prostate-mapping | 1 |
| 95 | re-heated | 1 |
| 96 | reduction/minute | 1 |
| 97 | s-pyrrolidino-piperidine | 1 |
| 98 | safe-guard | 1 |
| 99 | self-discharged | 1 |
| 100 | soluble/miscible | 1 |
| 101 | stereotypies/repetitive | 1 |
| 102 | sulfonamino | 1 |
| 103 | ti6n5 | 1 |
| 104 | trough-to-peak-ratios | 1 |
| 105 | undertaken.assessments | 1 |
| 106 | vaccinator | 1 |
| 107 | veering | 1 |
| 108 | vrk2 | 1 |
| 109 | whiteside | 1 |
| 110 | £55 | 1 |
| 111 | €204 | 1 |
| 1 | 'biased | 1 |
| 2 | 'friends | 2 |
| 3 | 'pain-free | 4 |
| 4 | 'pid | 1 |
| 5 | -admscs | 1 |
| 6 | -adsorber | 1 |
| 7 | -bonding | 1 |
| 8 | -stereospecificity | 1 |
| 9 | .74-.97 | 1 |
| 10 | .trends | 1 |
| 11 | /area | 2 |
| 12 | /gssg | 1 |
| 13 | /mfv | 1 |
| 14 | /obesity | 1 |
| 15 | /rtv | 2 |
| 16 | 0.20mg/ml | 1 |
| 17 | 0.546±0.027 | 1 |
| 18 | 117±33 | 1 |
| 19 | 13°c/w | 1 |
| 20 | 16.1/100py | 1 |
| 21 | 16.7t/ha | 1 |
| 22 | 161±46 | 1 |
| 23 | 18/5m | 1 |
| 24 | 18α-ga | 1 |
| 25 | 1в | 1 |
| 26 | 201±30 | 1 |
| 27 | 312±48 | 1 |
| 28 | 4.3μg/ml | 1 |
| 29 | 4.6±2.8°c | 1 |
| 30 | 5.85+/-0.63 | 1 |
| 31 | 65.9/100py | 1 |
| 32 | 7,233 | 1 |
| 33 | 8.6t/ha | 1 |
| 34 | =.90-.95 | 1 |
| 35 | acarabose | 1 |
| 36 | aiming | 998 |
| 37 | andlook | 1 |
| 38 | ap-plied | 2 |
| 39 | arrives | 25 |
| 40 | arylguanidines | 1 |
| 41 | b-cranberry | 1 |
| 42 | babbled | 1 |
| 43 | benevolently | 1 |
| 44 | bruising/hematoma | 3 |
| 45 | carbodiamide | 1 |
| 46 | cd4-cd8+high | 1 |
| 47 | ch58 | 1 |
| 48 | chorizo | 2 |
| 49 | clostridiales-dominated | 1 |
| 50 | crosssensitivity | 1 |
| 51 | d-aib | 8 |
| 52 | dendritogenesis | 1 |
| 53 | directed | 2,423 |
| 54 | equalising | 1 |
| 55 | erring | 1 |
| 56 | excelling | 1 |
| 57 | fabricii | 1 |
| 58 | frangible | 2 |
| 59 | gazing | 11 |
| 60 | geared | 64 |
| 61 | glances | 3 |
| 62 | helenien | 1 |
| 63 | hypo-intense | 4 |
| 64 | l-lysine-hcl | 2 |
| 65 | leans | 3 |
| 66 | linac-mr | 2 |
| 67 | liposomes/cell | 1 |
| 68 | looked | 557 |
| 69 | looking | 664 |
| 70 | looks | 215 |
| 71 | militates | 4 |
| 72 | mini-bioreactors | 1 |
| 73 | mri-targeted | 2 |
| 74 | multiple-dosages | 1 |
| 75 | nct02038062 | 1 |
| 76 | normocreatininemic | 1 |
| 77 | not-confident | 1 |
| 78 | o-mri | 1 |
| 79 | omega-umbilicoplasty | 1 |
| 80 | owieża | 1 |
| 81 | parity/age | 3 |
| 82 | participants/investigators | 1 |
| 83 | pfoawastreated | 1 |
| 84 | pointing | 300 |
| 85 | post-adsorber | 1 |
| 86 | post-prayer | 1 |
| 87 | postcalcination | 1 |
| 88 | precalibrated | 1 |
| 89 | prophylacctically | 1 |
| 90 | prostate-mapping | 1 |
| 91 | re-heated | 1 |
| 92 | reduction/minute | 1 |
| 93 | resentments | 2 |
| 94 | s-pyrrolidino-piperidine | 1 |
| 95 | safe-guard | 1 |
| 96 | self-discharged | 1 |
| 97 | signposting | 2 |
| 98 | soluble/miscible | 1 |
| 99 | stereotypies/repetitive | 1 |
| 100 | striving | 41 |
| 101 | sulfonamino | 1 |
| 102 | thermostatted | 3 |
| 103 | ti6n5 | 1 |
| 104 | trough-to-peak-ratios | 1 |
| 105 | undertaken.assessments | 1 |
| 106 | vaccinator | 1 |
| 107 | veering | 1 |
| 108 | vrk2 | 1 |
| 109 | whiteside | 1 |
| 110 | £55 | 1 |
| 111 | €204 | 1 |
| 1 | 201±30 | 1 |
| 2 | nct02038062 | 1 |
| 3 | vrk2 | 1 |
| 4 | 7,233 | 1 |
| 5 | 117±33 | 1 |
| 6 | 5.85+/-0.63 | 1 |
| 7 | €204 | 1 |
| 8 | £55 | 1 |
| 9 | =.90-.95 | 1 |
| 10 | ti6n5 | 1 |
| 11 | 161±46 | 1 |
| 12 | 0.546±0.027 | 1 |
| 13 | .74-.97 | 1 |
| 14 | 312±48 | 1 |
| 15 | ch58 | 1 |
| 16 | /area | 2 |
| 17 | 18α-ga | 1 |
| 18 | 8.6t/ha | 1 |
| 19 | 16.7t/ha | 1 |
| 20 | bruising/hematoma | 3 |
| 21 | owieża | 1 |
| 22 | d-aib | 8 |
| 23 | normocreatininemic | 1 |
| 24 | 4.6±2.8°c | 1 |
| 25 | self-discharged | 1 |
| 26 | ap-plied | 2 |
| 27 | looked | 557 |
| 28 | babbled | 1 |
| 29 | geared | 64 |
| 30 | 'biased | 1 |
| 31 | re-heated | 1 |
| 32 | pfoawastreated | 1 |
| 33 | clostridiales-dominated | 1 |
| 34 | precalibrated | 1 |
| 35 | directed | 2,423 |
| 36 | mri-targeted | 2 |
| 37 | thermostatted | 3 |
| 38 | 'pid | 1 |
| 39 | safe-guard | 1 |
| 40 | carbodiamide | 1 |
| 41 | whiteside | 1 |
| 42 | 'pain-free | 4 |
| 43 | parity/age | 3 |
| 44 | soluble/miscible | 1 |
| 45 | frangible | 2 |
| 46 | s-pyrrolidino-piperidine | 1 |
| 47 | hypo-intense | 4 |
| 48 | acarabose | 1 |
| 49 | reduction/minute | 1 |
| 50 | stereotypies/repetitive | 1 |
| 51 | -bonding | 1 |
| 52 | looking | 664 |
| 53 | excelling | 1 |
| 54 | aiming | 998 |
| 55 | prostate-mapping | 1 |
| 56 | veering | 1 |
| 57 | erring | 1 |
| 58 | equalising | 1 |
| 59 | pointing | 300 |
| 60 | signposting | 2 |
| 61 | striving | 41 |
| 62 | gazing | 11 |
| 63 | /gssg | 1 |
| 64 | cd4-cd8+high | 1 |
| 65 | fabricii | 1 |
| 66 | o-mri | 1 |
| 67 | andlook | 1 |
| 68 | l-lysine-hcl | 2 |
| 69 | liposomes/cell | 1 |
| 70 | 0.20mg/ml | 1 |
| 71 | 4.3μg/ml | 1 |
| 72 | 18/5m | 1 |
| 73 | helenien | 1 |
| 74 | postcalcination | 1 |
| 75 | sulfonamino | 1 |
| 76 | chorizo | 2 |
| 77 | -adsorber | 1 |
| 78 | post-adsorber | 1 |
| 79 | post-prayer | 1 |
| 80 | linac-mr | 2 |
| 81 | vaccinator | 1 |
| 82 | -admscs | 1 |
| 83 | 'friends | 2 |
| 84 | .trends | 1 |
| 85 | glances | 3 |
| 86 | multiple-dosages | 1 |
| 87 | arylguanidines | 1 |
| 88 | militates | 4 |
| 89 | arrives | 25 |
| 90 | dendritogenesis | 1 |
| 91 | looks | 215 |
| 92 | leans | 3 |
| 93 | trough-to-peak-ratios | 1 |
| 94 | participants/investigators | 1 |
| 95 | mini-bioreactors | 1 |
| 96 | undertaken.assessments | 1 |
| 97 | resentments | 2 |
| 98 | not-confident | 1 |
| 99 | /mfv | 1 |
| 100 | /rtv | 2 |
| 101 | 13°c/w | 1 |
| 102 | prophylacctically | 1 |
| 103 | benevolently | 1 |
| 104 | 16.1/100py | 1 |
| 105 | 65.9/100py | 1 |
| 106 | b-cranberry | 1 |
| 107 | -stereospecificity | 1 |
| 108 | /obesity | 1 |
| 109 | crosssensitivity | 1 |
| 110 | omega-umbilicoplasty | 1 |
| 111 | 1в | 1 |